3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
141
Lung Neoplasms
51
Pancreatic Neoplasms
30
Non-Squamous Non-Small Cell Lung Cancer
18
Neoplasms
15
Adenocarcinoma of Lung
14
Head and Neck Neoplasms
13
Glioblastoma
13
Gliosarcoma
12
Breast Neoplasms
11
Brain Neoplasms
11
Neoplasm Metastasis
9
Carcinoma, Hepatocellular
9
Adenocarcinoma, Bronchiolo-Alveolar
9
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Squamous Cell
7
Carcinoma, Renal Cell
7
Astrocytoma
6
Oligodendroglioma
5
Carcinoma
5
Urinary Bladder Neoplasms
4
Liver Neoplasms
4
Glioma
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Adenocarcinoma
4
Recurrence
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Interventions
Cisplatin
9
Cetuximab
9
Radiotherapy, Intensity-Modulated
6
Sirolimus
2
Platinum
2
Fluorouracil
2
Docetaxel
2
Bevacizumab
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
temsirolimus
1
sargramostim
1
saracatinib
1
dehydroftorafur
1
adavosertib
1
Vorinostat
1
Trioxsalen
1
Tobacco Use Cessation Devices
1
Soybean Proteins
1
Sorafenib
1
Salts
1
Pilocarpine
1
Phototherapy
1
Photochemotherapy
1
Paclitaxel
1
NVP-BKM120
1
Moxibustion
1
Irinotecan
1
Immunoglobulin G
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Tongue Neoplasms
×
Erlotinib Hydrochloride
×
Clear all
No trials found.